Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ)

CNY 2.22

(-0.45%)

EBITDA Summary of Shenzhen Neptunus Bioengineering Co., Ltd.

  • Shenzhen Neptunus Bioengineering Co., Ltd.'s latest annual EBITDA in 2023 was -141.51 Million CNY , down -5.74% from previous year.
  • Shenzhen Neptunus Bioengineering Co., Ltd.'s latest quarterly EBITDA in 2024 Q3 was 227.74 Million CNY , down -13.5% from previous quarter.
  • Shenzhen Neptunus Bioengineering Co., Ltd. reported an annual EBITDA of 523.19 Million CNY in 2022, down -38.51% from previous year.
  • Shenzhen Neptunus Bioengineering Co., Ltd. reported an annual EBITDA of 1.72 Billion CNY in 2021, down -5.33% from previous year.
  • Shenzhen Neptunus Bioengineering Co., Ltd. reported a quarterly EBITDA of 309.86 Million CNY for 2024 Q1, up 124.1% from previous quarter.
  • Shenzhen Neptunus Bioengineering Co., Ltd. reported a quarterly EBITDA of 227.74 Million CNY for 2024 Q3, down -13.5% from previous quarter.

Annual EBITDA Chart of Shenzhen Neptunus Bioengineering Co., Ltd. (2023 - 1995)

Historical Annual EBITDA of Shenzhen Neptunus Bioengineering Co., Ltd. (2023 - 1995)

Year EBITDA EBITDA Growth
2023 -141.51 Million CNY -5.74%
2022 523.19 Million CNY -38.51%
2021 1.72 Billion CNY -5.33%
2020 1.42 Billion CNY -21.99%
2019 2.24 Billion CNY 10.7%
2018 2.1 Billion CNY 49.73%
2017 1.66 Billion CNY 73.55%
2016 950.22 Million CNY -5.57%
2015 994.65 Million CNY 121.29%
2014 420.12 Million CNY -25.1%
2013 587.16 Million CNY 81.02%
2012 329.83 Million CNY 13.06%
2011 275.66 Million CNY 10.33%
2010 270.8 Million CNY 81.92%
2009 50 Million CNY -10.21%
2008 41.35 Million CNY -28.05%
2007 118.78 Million CNY 34.17%
2006 171.19 Million CNY 128.1%
2005 -600.47 Million CNY -514.15%
2004 144.98 Million CNY 244.93%
2003 135.8 Million CNY -170.03%
2002 142.86 Million CNY -18.93%
2001 163.12 Million CNY 35.73%
2000 122.66 Million CNY 227.22%
1999 39.67 Million CNY 34.74%
1998 27.72 Million CNY 46.0%
1997 20.16 Million CNY 4.91%
1996 19.22 Million CNY 74.86%
1995 10.99 Million CNY 0.0%

Peer EBITDA Comparison of Shenzhen Neptunus Bioengineering Co., Ltd.

Name EBITDA EBITDA Difference
Anhui Fengyuan Pharmaceutical Co., Ltd. 388.66 Million CNY 136.41%
Dong-E-E-Jiao Co.,Ltd. 1.53 Billion CNY 109.192%
Livzon Pharmaceutical Group Inc. 3.29 Billion CNY 104.292%
Hainan Haiyao Co., Ltd. 152.19 Million CNY 192.979%
Tus-Pharmaceutical Group Co., Ltd. 62.18 Million CNY 327.573%
Jilin Aodong Pharmaceutical Group Co., Ltd. 1.87 Billion CNY 107.534%
Changchun High-Tech Industries (Group) Inc. 6.09 Billion CNY 102.321%
Apeloa Pharmaceutical Co.,Ltd 1.79 Billion CNY 107.897%
PKU HealthCare Corp.,Ltd. 132.39 Million CNY 206.888%
Chengdu Huasun Technology Group Inc., Ltd. 74.04 Million CNY 291.116%
Dezhan Healthcare Company Limited 219.36 Million CNY 164.511%
Jinling Pharmaceutical Company Limited 249.63 Million CNY 156.689%
Jiuzhitang Co., Ltd. 460.28 Million CNY 130.744%
Huapont Life Sciences Co., Ltd. 2.12 Billion CNY 106.652%
Zhejiang Jingxin Pharmaceutical Co., Ltd. 945.42 Million CNY 114.968%
Shandong Wohua Pharmaceutical Co., Ltd. 87.98 Million CNY 260.828%
Hengkang Medical Group Co., Ltd. 348.09 Million CNY 140.653%
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 453.78 Million CNY 131.185%
Qianjiang Yongan Pharmaceutical Co., Ltd. 141.6 Million CNY 199.932%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 124.71 Million CNY 213.464%
Jinhe Biotechnology CO., LTD. 345.42 Million CNY 140.968%
Teyi Pharmaceutical Group Co.,Ltd 369.46 Million CNY 138.302%
Kunming Longjin Pharmaceutical Co., Ltd. -31.19 Million CNY -353.596%
Beijing Aosaikang Pharmaceutical Co., Ltd. -112.74 Million CNY -25.514%
Chengdu Kanghong Pharmaceutical Group Co., Ltd 1.38 Billion CNY 110.191%
Anhui Huangshan Capsule Co., Ltd. 118.18 Million CNY 219.735%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd 166.4 Million CNY 185.039%
Zhuhai Rundu Pharmaceutical Co., Ltd. 215.02 Million CNY 165.812%
Huaren Pharmaceutical Co., Ltd. 431.65 Million CNY 132.784%
Tianjin Ringpu Bio-Technology Co.,Ltd. 711.43 Million CNY 119.891%
Shanxi Zhendong Pharmaceutical Co.,Ltd 94.75 Million CNY 249.347%
Fuan Pharmaceutical (Group) Co., Ltd. 528.99 Million CNY 126.751%
Hybio Pharmaceutical Co., Ltd. -233.61 Million CNY 39.425%
Baotou Dongbao Bio-Tech Co.,Ltd 236.24 Million CNY 159.9%
Hunan Er-Kang Pharmaceutical Co., Ltd 12.02 Million CNY 1277.063%
Changjiang Pharmaceutical Group Co., Ltd. -572.69 Million CNY 75.29%
Zhejiang Garden Bio-chemical High-tech Co., Ltd. 383.11 Million CNY 136.937%
Fujian Cosunter Pharmaceutical Co., Ltd. -190.85 Million CNY 25.855%
Beijing Science Sun Pharmaceutical Co., Ltd. 7.7 Million CNY 1937.092%
Zhejiang Xinguang Pharmaceutical Co., Ltd. 87.94 Million CNY 260.9%
Hainan Poly Pharm. Co., Ltd 309.33 Million CNY 145.747%
Jiangxi Synergy Pharmaceutical Co., Ltd. 192.54 Million CNY 173.497%
Wuhan Hiteck Biological Pharma Co.,Ltd -73.65 Million CNY -92.122%
Shandong Xinhua Pharmaceutical Company Limited 1.09 Billion CNY 112.916%
Zhejiang Tianyu Pharmaceutical Co., Ltd. 435.22 Million CNY 132.514%
PharmaBlock Sciences (Nanjing), Inc. 380.8 Million CNY 137.161%
Jinghua Pharmaceutical Group Co., Ltd. 417.61 Million CNY 133.886%
Zhejiang Hisoar Pharmaceutical Co., Ltd. -43.99 Million CNY -221.662%
Betta Pharmaceuticals Co., Ltd. 696.09 Million CNY 120.329%
Tibet AIM Pharm. Inc. 50.76 Million CNY 378.775%
Shenzhen Kangtai Biological Products Co., Ltd. 1.29 Billion CNY 110.927%
Shandong Shanda Wit Science and Technology Co., Ltd. 1.39 Billion CNY 110.116%
Pacific Shuanglin Bio-pharmacy Co., LTD 841.98 Million CNY 116.807%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. 300.14 Million CNY 147.148%
Xiamen Kingdomway Group Company 588.78 Million CNY 124.035%
ShanXi C&Y Pharmaceutical Group Co., Ltd. 127.06 Million CNY 211.37%
Walvax Biotechnology Co., Ltd. 938.22 Million CNY 115.083%
Sunflower Pharmaceutical Group Co.,Ltd 1.54 Billion CNY 109.148%
Harbin Gloria Pharmaceuticals Co., Ltd 275.28 Million CNY 151.406%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 4.68 Billion CNY 103.019%
Hunan Hansen Pharmaceutical Co., Ltd. 280.66 Million CNY 150.421%
Changzhou Qianhong Biopharma CO.,LTD 278.66 Million CNY 150.782%
Shenzhen Weiguang Biological Products Co., Ltd. 350.21 Million CNY 140.407%
Honz Pharmaceutical Co., Ltd. 133.53 Million CNY 205.975%
Northeast Pharmaceutical Group Co., Ltd. 1.19 Billion CNY 111.827%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd 217.47 Million CNY 165.071%
Guizhou Xinbang Pharmaceutical Co., Ltd. 654.01 Million CNY 121.637%
Tianjin Lisheng Pharmaceutical Co.,Ltd. 477.37 Million CNY 129.644%
Zhejiang Yatai Pharmaceutical Co., Ltd. 76.31 Million CNY 285.435%
Zhejiang NHU Company Ltd. 5.24 Billion CNY 102.697%
ApicHope Pharmaceutical Co., Ltd 464.04 Million CNY 130.496%
Shanghai Kaibao Pharmaceutical CO.,Ltd 375.33 Million CNY 137.703%
Beijing SL Pharmaceutical Co., Ltd. 610.29 Million CNY 123.188%
Yunnan Baiyao Group Co.,Ltd 5.2 Billion CNY 102.718%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD 127.72 Million CNY 210.798%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. 228.9 Million CNY 161.822%
Guangdong Lifestrong Pharmacy Co., Ltd. 50.95 Million CNY 377.693%
Huadong Medicine Co., Ltd 4.61 Billion CNY 103.065%
Jiangsu Nhwa Pharmaceutical Co., LTD 1.33 Billion CNY 110.568%
Harbin Medisan Pharmaceutical Co., Ltd. 183.66 Million CNY 177.049%
LanZhou Foci Pharmaceutical Co.,Ltd. 135.36 Million CNY 204.538%
Tianjin Chase Sun Pharmaceutical Co.,Ltd 1.04 Billion CNY 113.516%
Beijing Beilu Pharmaceutical Co., Ltd 36.44 Million CNY 488.283%
Nanjing Hicin Pharmaceutical Co., Ltd. 97 Million CNY 245.887%
Renhe Pharmacy Co., Ltd. 1.05 Billion CNY 113.469%
Chongqing Pharscin Pharmaceutical Co., Ltd. 125.84 Million CNY 212.447%
Zhejiang Xianju Pharmaceutical Co.,Ltd. 863.95 Million CNY 116.379%
Luoxin Pharmaceuticals Group Stock Co., Ltd. -320.08 Million CNY 55.79%
Guizhou Bailing Group Pharmaceutical Co., Ltd. -298.6 Million CNY 52.61%